[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362050-105":59,"doc-detail-362050-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","autophagy-a-novel-target-in-order-to-overcome-drug-resistance-in-pancreatic-adenocarcinoma","Autophagy: a novel target in order to overcome drug resistance in pancreatic adenocarcinoma","","Pancreatic adenocarcinoma accounts for the majority of pancreatic cancer cases, yet late diagnosis and extreme chemoresistance contribute to poor outcomes and predominantly palliative care. This review explains how autophagy can function as a “double-edged sword” in cancer, often enabling tumor cells to survive treatment-induced stress from drugs and radiation. It highlights autophagy inhibitors such as chloroquine and hydroxychloroquine, and discusses strategies combining antineoplastic agents to suppress therapy-triggered autophagy. Regulatory signaling pathways and molecules controlling drug-induced autophagy, including PI3K-Akt-mTOR, HMGB1-mediated mechanisms, and other routes, are examined to identify more effective approaches.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/autophagy-a-novel-target-in-order-to-overcome-drug-resistance-in-pancreatic-adenocarcinoma/362050/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/autophagy-a-novel-target-in-order-to-overcome-drug-resistance-in-pancreatic-adenocarcinoma/362050.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is autophagy considered important in pancreatic adenocarcinoma treatment?","Question",{"text":112,"@type":113},"Pancreatic cancer shows strong resistance to chemotherapy and radiotherapy, and treatment can induce autophagy as a protective response. Limiting this treatment-induced autophagy may improve therapeutic effectiveness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the rationale for using autophagy inhibitors in combination therapy?",{"text":117,"@type":113},"Autophagy inhibitors are expected to improve sensitivity of cancer cells to antineoplastic drugs that activate autophagy. This combination aims to reduce autophagy-mediated cytoprotection.",{"name":119,"@type":110,"acceptedAnswer":120},"Which autophagy regulators and signaling pathways are discussed in the review?",{"text":121,"@type":113},"The review highlights PI3K-Akt-mTOR as a primary autophagy regulator and describes other signaling pathways involved in drug-induced autophagy, including HMGB1-linked mechanisms and MAPK/ERK-related signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362050,1790633992,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cite this article: Amiri BS, Naserranjbar M, Aliabadi F, Hejrati A, Hejrati L. 2025 Autophagy: a novel target in order to overcome drug resistance in pancreatic adenocarcinoma. Open Biol. 15: 240412.  \n[https://doi.org/10.1098/rsob.240412](https://doi.org/10.1098/rsob.240412)  \n[Received: 23 December 2024](Received: 23 December 2024)  \n[Accepted: 3 June 2025](Accepted: 3 June 2025)  \nSubject Areas:  \nmolecular biology, cellular biology  \nKeywords:  \npancreatic cancer, pancreatic adenocarcinoma, drug resistance, autophagy, regulating factors  \nAuthor for correspondence:  \nFatemeh Aliabadi  \ne-mail: [aliabadi96f@gmail.com](aliabadi96f@gmail.com)  \nAutophagy: a novel target in order to overcome drug resistance in pancreatic adenocarcinoma  \nBahareh Shateri Amiri1, Mehrasa Naserranjbar2, Fatemeh Aliabadi2, Alireza Hejrati1 and Lina Hejrati2  \n1Department of Internal Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran  \n2Department of Medicine, Iran University of Medical Sciences, Tehran, Iran  FA, 0009-0002-2669-2749  \nTypically, unchecked pancreatic cell proliferation results in the development of pancreatic cancer, which has the potential to spread to other bodily organs. About 90% of instances of pancreatic cancer are pancreatic adenocarcinomas. About 10–20% of pancreatic carcinomas are resectable and potentially curable, and the 5-year survival rate is only 4%; as a result, the majority of pancreatic cancer treatments are palliative in nature. Surgical resection is the only curative treatment; however, because of late diagnosis, the majority of patients appear atan advanced stage, and only a small percentage (10–20%) of them are candidates for surgery. Due to pancreatic cancer’s strong resistance to practically all chemotherapeutic drugs and conventional radiotherapies, conventional radiation and chemotherapies have little effectiveness in extending patients’ overall life. A lot of scientific studies, however, frequently use the metaphorical term ‘double-edged sword’ to indicate how autophagy plays a different function in cancer. The use of autophagy inhibitors is thought to be advantageous in combining antineoplastic drugs to improve the sensitivity of cancer cells to therapeutic compounds that activate autophagy. In this review, we aim to look into autophagy along with searching for the most effective strategy in order to treat pancreatic adenocarcinoma with the least drug resistance.  \n1. Introduction  \nSince autophagic pathways are being targeted by autophagy inhibitors like chloroquine (CQ) and hydroxychloroquine (HCQ), which have previously received clinical approval, it is possible to find and create more advanced and potent cancer therapy strategies. When exposed to medicines or radiation, cancer cells begin to engage in autophagy to protect themselves. Therefore, there is a lot of interest in finding ways to limit treatment-induced autophagy in order to increase the effectiveness of cancer therapies [1] . The use of autophagy inhibitors is thought to be advantageous in combining antineoplastic drugs to improve the sensitivity of cancer cells to therapeutic compounds that activate autophagy [2,3] .  \nA lot of scientific studies, however, frequently use the metaphorical term‘double-edged sword’ to indicate how autophagy plays different functions in cancer. These investigations mainly rely on genetically modified mouse models (GEMM) and identification of DNA mutations, which permitted the designation of various ATG genes as either ‘tumour suppressors’ or ‘oncogenes’ since they directly affect the biochemical control of autophagy [4,5] .  \n© 2025 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, provided the original author and source are credited.  \nNumerous substances, including mTOR inhibitors, kinase i","cbCaiqMWDKWj3dHQ","https://ap.wps.com/l/cbCaiqMWDKWj3dHQ","pdf",691796,15,"English","# Introduction\n## Autophagy inhibition and treatment-induced autophagy\n## Autophagy as a “double-edged sword” in cancer","[{\"question\":\"Why is autophagy considered important in pancreatic adenocarcinoma treatment?\",\"answer\":\"Pancreatic cancer shows strong resistance to chemotherapy and radiotherapy, and treatment can induce autophagy as a protective response. Limiting this treatment-induced autophagy may improve therapeutic effectiveness.\"},{\"question\":\"What is the rationale for using autophagy inhibitors in combination therapy?\",\"answer\":\"Autophagy inhibitors are expected to improve sensitivity of cancer cells to antineoplastic drugs that activate autophagy. This combination aims to reduce autophagy-mediated cytoprotection.\"},{\"question\":\"Which autophagy regulators and signaling pathways are discussed in the review?\",\"answer\":\"The review highlights PI3K-Akt-mTOR as a primary autophagy regulator and describes other signaling pathways involved in drug-induced autophagy, including HMGB1-linked mechanisms and MAPK/ERK-related signaling.\"}]","Autophagy: a novel target in order to overcome drug resistance in pancreatic adenocarcinoma | PDF",1790146347,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c997838c73008b83e0250c0f0034214.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c23683fce921cf09b47c51e5bddb7935.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc3d7e743fc4c75f7657767f4c61ab4b.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7553dc241778bf6c8ce5f1793cb8dfb3.webp",980,1385]